Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 9462571, 11 pages
http://dx.doi.org/10.1155/2016/9462571
Research Article

Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis

1School of Biology and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, Hubei 430023, China
2School of Medicine, Jianghan University, Wuhan, Hubei, China
3Department of Blood Transfusion, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Received 17 November 2015; Accepted 11 February 2016

Academic Editor: Dongmin Liu

Copyright © 2016 Yu Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Unger and P. E. Scherer, “Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity,” Trends in Endocrinology and Metabolism, vol. 21, no. 6, pp. 345–352, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Angulo, “Nonalcoholic fatty liver disease,” The New England Journal of Medicine, vol. 346, no. 16, pp. 1221–1231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two ‘hits’?” Gastroenterology, vol. 114, no. 4 I, pp. 842–845, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. G. C. Farrell and C. Z. Larter, “Nonalcoholic fatty liver disease: from steatosis to cirrhosis,” Hepatology, vol. 43, no. 2, supplement 1, pp. S99–S112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Mouzaki, E. M. Comelli, B. M. Arendt et al., “Intestinal microbiota in patients with nonalcoholic fatty liver disease,” Hepatology, vol. 58, no. 1, pp. 120–127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Qin, R. Li, J. Raes et al., “A human gut microbial gene catalogue established by metagenomic sequencing,” Nature, vol. 464, no. 7285, pp. 59–65, 2010. View at Publisher · View at Google Scholar
  7. S. Yoshimoto, T. M. Loo, K. Atarashi et al., “Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome,” Nature, vol. 499, no. 7456, pp. 97–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Tremaroli and F. Bäckhed, “Functional interactions between the gut microbiota and host metabolism,” Nature, vol. 489, no. 7415, pp. 242–249, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, “An obesity-associated gut microbiome with increased capacity for energy harvest,” Nature, vol. 444, no. 7122, pp. 1027–1031, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Backhed, H. Ding, T. Wang et al., “The gut microbiota as an environmental factor that regulates fat storage,” Proceedings of the National Academy of Sciences, vol. 101, no. 44, pp. 15718–15723, 2004. View at Publisher · View at Google Scholar
  11. A. Vrieze, F. Holleman, E. G. Zoetendal, W. M. De Vos, J. B. L. Hoekstra, and M. Nieuwdorp, “The environment within: how gut microbiota may influence metabolism and body composition,” Diabetologia, vol. 53, no. 4, pp. 606–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. D. Cani, J. Amar, M. A. Iglesias et al., “Metabolic endotoxemia initiates obesity and insulin resistance,” Diabetes, vol. 56, no. 7, pp. 1761–1772, 2007. View at Publisher · View at Google Scholar
  13. J. Drewe, C. Beglinger, and G. Fricker, “Effect of ischemia on intestinal permeability of lipopolysaccharides,” European Journal of Clinical Investigation, vol. 31, no. 2, pp. 138–144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Wang, G. Xiao, Y. Yao, S. Guo, K. Lu, and Z. Sheng, “The role of bifidobacteria in gut barrier function after thermal injury in rats,” Journal of Trauma, vol. 61, no. 3, pp. 650–657, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. P. D. Cani, S. Possemiers, T. Van De Wiele et al., “Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability,” Gut, vol. 58, no. 8, pp. 1091–1103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Vijay-Kumar, J. D. Aitken, F. A. Carvalho et al., “Metabolie syndrome and altered gut microbiota in mice lacking Toll-like receptor 5,” Science, vol. 328, no. 5975, pp. 228–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Miura, Y. Kodama, S. Inokuchi et al., “Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice,” Gastroenterology, vol. 139, no. 1, pp. 323.e7–334.e7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Miura and H. Ohnishi, “Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7381–7391, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Scorletti and C. D. Byrne, “Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease,” Annual Review of Nutrition, vol. 33, pp. 231–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Monteiro, M. Leslie, M. H. Moghadasian, B. M. Arendt, J. P. Allard, and D. W. L. Ma, “The role of n-6 and n-3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease,” Food & Function, vol. 5, no. 3, pp. 426–435, 2014. View at Publisher · View at Google Scholar
  21. N. de Wit, M. Derrien, H. Bosch-Vermeulen et al., “Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 303, no. 5, pp. G589–G599, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Chen, F. Yang, H. Lu et al., “Characterization of fecal microbial communities in patients with liver cirrhosis,” Hepatology, vol. 54, no. 2, pp. 562–572, 2011. View at Publisher · View at Google Scholar
  23. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” The Journal of Clinical Investigation, vol. 116, no. 1, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Cohen, J. D. Horton, and H. H. Hobbs, “Human fatty liver disease: old questions and new insights,” Science, vol. 332, no. 6037, pp. 1519–1523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. G. S. Masterton, J. N. Plevris, and P. C. Hayes, “Review article: omega-3 fatty acids—a promising novel therapy for non-alcoholic fatty liver disease,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 7, pp. 679–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. M. Parker, N. A. Johnson, C. A. Burdon, J. S. Cohn, H. T. O'Connor, and J. George, “Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis,” Journal of Hepatology, vol. 56, no. 4, pp. 944–951, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Yuan, H. Wang, Y. Tian et al., “Fish oil alleviated high-fat diet–induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study,” Lipids in Health and Disease, vol. 15, no. 1, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  28. J. R. Swann, E. J. Want, F. M. Geier et al., “Systemic gut microbial modulation of bile acid metabolism in host tissue compartments,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, supplement 1, pp. 4523–4530, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. F. Gregor and G. S. Hotamisligil, “Inflammatory mechanisms in obesity,” Annual Review of Immunology, vol. 29, no. 1, pp. 415–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Shapiro, M. Tehilla, J. Attal-Singer, R. Bruck, R. Luzzatti, and P. Singer, “The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease,” Clinical Nutrition, vol. 30, no. 1, pp. 6–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. R. Moschen, S. Kaser, and H. Tilg, “Non-alcoholic steatohepatitis: a microbiota-driven disease,” Trends in Endocrinology and Metabolism, vol. 24, no. 11, pp. 537–545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. B. M. Carvalho, D. Guadagnini, D. M. L. Tsukumo et al., “Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice,” Diabetologia, vol. 55, no. 10, pp. 2823–2834, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Zhu, S. S. Baker, C. Gill et al., “Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH,” Hepatology, vol. 57, no. 2, pp. 601–609, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. E.-Y. Choi, J.-Y. Jin, J.-I. Choi, I. S. Choi, and S.-J. Kim, “DHA suppresses Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages,” British Journal of Nutrition, vol. 111, no. 7, pp. 1221–1230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Michail, M. Lin, M. R. Frey et al., “Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease,” FEMS Microbiology Ecology, vol. 91, no. 2, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  36. A. Everard, C. Belzer, L. Geurts et al., “Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 22, pp. 9066–9071, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Patterson, R. M. O'Doherty, E. F. Murphy et al., “Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice,” British Journal of Nutrition, vol. 111, no. 11, pp. 1905–1917, 2014. View at Publisher · View at Google Scholar · View at Scopus